Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist–physician collaboration in the outpatient department
Thanompong Sathienluckana,1 Weerapon Unaharassamee,2 Chuthamanee Suthisisang,3 Orabhorn Suanchang,4 Thanarat Suansanae5 1Faculty of Pharmacy, Siam University, Bangkok, Thailand; 2Department of Psychiatry, Somdet Chaopraya Institute of Psychiatry, Bangkok, Thailand; 3Department of Pharmacology, Facul...
Saved in:
Main Authors: | Sathienluckana T (Author), Unaharassamee W (Author), Suthisisang C (Author), Suanchang O (Author), Suansanae T (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clozapine discontinuation withdrawal symptoms in schizophrenia
by: Graham Blackman, et al.
Published: (2021) -
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort
by: Nathan Vidal, et al.
Published: (2024) -
Impact of physician−pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study
by: Kimihiko Urano, et al.
Published: (2020) -
Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate
by: Hernán Ramos, et al.
Published: (2021) -
Collaborative attitudes between pharmacists and physicians in Brazil
by: Fernanda Oliveira Prado, et al.
Published: (2023)